Isis Pharmaceuticals, J&J deal

Isis and Johnson & Johnson’s Janssen Biotech Inc. unit partnered to discover and develop antisense drugs to treat autoimmune disorders of the GI tract. Isis will contribute its RNA-targeted technology...